Old Web
English
Sign In
Acemap
>
authorDetail
>
Helena Arozenius
Helena Arozenius
Medicine
Antagonist
5-HT2B receptor
Physical therapy
Pharmacology
6
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An orally available, highly selective 5-hydroxytryptamine 2B (5-HT2B) receptor antagonist ameliorating pulmonary and dermal fibrosis
2019
European Respiratory Journal
Christina Wenglén
Helena Arozenius
Lars Pettersson
Gunilla Ekström
Show All
Source
Cite
Save
Citations (1)
Evaluation of a selective 5-hydroxytryptamine 2B receptor antagonist designed to alter the fibrotic process
2017
European Respiratory Journal
Christina Wenglén
Lars Pettersson
Helena Arozenius
Gunilla Ekström
Show All
Source
Cite
Save
Citations (0)
SAT0314 A novel highly selective 5-hydroxytryptamine 2B (5-HT2B) receptor antagonist ameliorating fibrosis in preclinical models of systemic sclerosis
2017
Annals of the Rheumatic Diseases
Christina Wenglén
Lars Pettersson
Helena Arozenius
Gunilla Ekström
Show All
Source
Cite
Save
Citations (1)
FRI0011 5-ht2b receptor antagonists reduce inflammation and pain
2013
Annals of the Rheumatic Diseases
Niklas Palmqvist
Christina Wenglén
Anders Sjodin
A.-C. Ryde
M. Siller
Helena Arozenius
A. Mathisson
C. Klint
A. Pramhed
Lars Pettersson
Gunilla Ekström
Show All
Source
Cite
Save
Citations (1)
1